128 related articles for article (PubMed ID: 15278007)
1. Levosimendan in patients with cardiogenic shock undergoing surgical revascularization: a case series.
Lehmann A; Lang J; Boldt J; Isgro F; Kiessling AH
Med Sci Monit; 2004 Aug; 10(8):MT89-93. PubMed ID: 15278007
[TBL] [Abstract][Full Text] [Related]
2. Levosimendan in patients with acute myocardial ischaemia undergoing emergency surgical revascularization.
Lehmann A; Kiessling AH; Isgro F; Zeitler C; Thaler E; Boldt J
Eur J Anaesthesiol; 2008 Mar; 25(3):224-9. PubMed ID: 17892614
[TBL] [Abstract][Full Text] [Related]
3. The effects of Levosimendan on global haemodynamics in patients with cardiogenic shock.
Rokyta R; Pechman V
Neuro Endocrinol Lett; 2006; 27(1-2):121-7. PubMed ID: 16648778
[TBL] [Abstract][Full Text] [Related]
4. Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan.
Russ MA; Prondzinsky R; Carter JM; Schlitt A; Ebelt H; Schmidt H; Lemm H; Heinroth K; Soeffker G; Winkler M; Werdan K; Buerke M
Crit Care Med; 2009 Dec; 37(12):3017-23. PubMed ID: 19661807
[TBL] [Abstract][Full Text] [Related]
5. Levosimendan as rescue therapy in severe cardiogenic shock after ST-elevation myocardial infarction.
Greif M; Zwermann L; Reithmann C; Weis M
Acute Card Care; 2008; 10(3):185-90. PubMed ID: 18972629
[TBL] [Abstract][Full Text] [Related]
6. Early and sustained haemodynamic improvement with levosimendan compared to intraaortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction.
Christoph A; Prondzinsky R; Russ M; Janusch M; Schlitt A; Lemm H; Reith S; Werdan K; Buerke M
Acute Card Care; 2008; 10(1):49-57. PubMed ID: 17924229
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock.
Russ MA; Prondzinsky R; Christoph A; Schlitt A; Buerke U; Söffker G; Lemm H; Swyter M; Wegener N; Winkler M; Carter JM; Reith S; Werdan K; Buerke M
Crit Care Med; 2007 Dec; 35(12):2732-9. PubMed ID: 17893627
[TBL] [Abstract][Full Text] [Related]
8. Levosimendan in the treatment of cardiogenic shock.
Buerkem B; Lemm H; Krohe K; Dietz S; Raaz U; Buerke U; Russ M; Schlitt A; Werdan K
Minerva Cardioangiol; 2010 Aug; 58(4):519-30. PubMed ID: 20938415
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based use of levosimendan in different clinical settings.
De Luca L; Colucci WS; Nieminen MS; Massie BM; Gheorghiade M
Eur Heart J; 2006 Aug; 27(16):1908-20. PubMed ID: 16682381
[TBL] [Abstract][Full Text] [Related]
10. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.
Ponschab M; Hochmair N; Ghazwinian N; Mueller T; Plöchl W
Eur J Anaesthesiol; 2008 Aug; 25(8):627-33. PubMed ID: 18405408
[TBL] [Abstract][Full Text] [Related]
11. Levosimendan in cardiogenic shock: the magic drug for every patient?
Smetana P; Geppert A
Crit Care Med; 2007 Dec; 35(12):2862-4. PubMed ID: 18043208
[No Abstract] [Full Text] [Related]
12. Effects of levosimendan versus dobutamine on left ventricular diastolic function in patients with cardiogenic shock after primary angioplasty.
Dominguez-Rodriguez A; Samimi-Fard S; Garcia-Gonzalez MJ; Abreu-Gonzalez P
Int J Cardiol; 2008 Aug; 128(2):214-7. PubMed ID: 17643535
[TBL] [Abstract][Full Text] [Related]
13. Levosimendan in perioperative and critical care patients.
Salmenperä M; Eriksson H
Curr Opin Anaesthesiol; 2009 Aug; 22(4):496-501. PubMed ID: 19502977
[TBL] [Abstract][Full Text] [Related]
14. Levosimendan in aortic valve surgery: cardiac performance and recovery.
Järvelä K; Maaranen P; Sisto T; Ruokonen E
J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):693-8. PubMed ID: 18922425
[TBL] [Abstract][Full Text] [Related]
15. Levosimendan for weaning from cardiopulmonary bypass after coronary artery bypass grafting.
Akgul A; Mavioglu L; Katircioglu SF; Pac M; Cobanoglu A
Heart Lung Circ; 2006 Oct; 15(5):320-4. PubMed ID: 16860605
[TBL] [Abstract][Full Text] [Related]
16. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance.
Tsagalou EP; Kanakakis J; Anastasiou-Nana MI; Drakos SG; Ntalianis AS; Malliaras K; Lazaris N; Katsaros F; Nanas JN
Acute Card Care; 2009; 11(2):99-106. PubMed ID: 19353405
[TBL] [Abstract][Full Text] [Related]
18. Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics.
García-González MJ; Domínguez-Rodríguez A; Ferrer-Hita JJ; Abreu-González P; Muñoz MB
Eur J Heart Fail; 2006 Nov; 8(7):723-8. PubMed ID: 16492404
[TBL] [Abstract][Full Text] [Related]
19. Effects of levosimendan on indocyanine green plasma disappearance rate and the gastric mucosal-arterial pCO2 gradient in abdominal aortic aneurysm surgery.
Leppikangas H; Tenhunen JJ; Lindgren L; Salenius JP; Ruokonen E
Acta Anaesthesiol Scand; 2008 Jul; 52(6):785-92. PubMed ID: 18477074
[TBL] [Abstract][Full Text] [Related]
20. Levosimendan versus an intra-aortic balloon pump in high-risk cardiac patients.
Lomivorotov VV; Boboshko VA; Efremov SM; Kornilov IA; Chernyavskiy AM; Lomivorotov VN; Knazkova LG; Karaskov AM
J Cardiothorac Vasc Anesth; 2012 Aug; 26(4):596-603. PubMed ID: 22051419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
